Edges in Network
Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | CFL1 |
Upstream (Parents) |
---|
(<<) ACTB → CFL1 |
(<<) CYB5R3 → CFL1 |
(<<) DAZAP2 → CFL1 |
(<<) ENO1 → CFL1 |
(<<) HSPA8 → CFL1 |
(<<) PPIF → CFL1 |
(<<) RHOA → CFL1 |
Downstream (Children) |
---|
CFL1 → ADAM15 (>>) |
CFL1 → ADRBK1 (>>) |
CFL1 → ANXA2 (>>) |
CFL1 → ATP2A2 (>>) |
CFL1 → BCL2L1 (>>) |
CFL1 → CAT (>>) |
CFL1 → DNAJA1 (>>) |
CFL1 → DVL3 (>>) |
CFL1 → EFHD2 (>>) |
CFL1 → EHD1 (>>) |
CFL1 → ELOVL1 (>>) |
CFL1 → GAPDH (>>) |
CFL1 → GNB2 (>>) |
CFL1 → GPX1 (>>) |
CFL1 → GPX4 (>>) |
CFL1 → HDAC10 (>>) |
CFL1 → HES1 (>>) |
CFL1 → HPCAL1 (>>) |
CFL1 → ID1 (>>) |
CFL1 → ILK (>>) |
CFL1 → INPPL1 (>>) |
CFL1 → JUND (>>) |
CFL1 → KCTD5 (>>) |
CFL1 → KLF6 (>>) |
CFL1 → KPNA1 (>>) |
CFL1 → LRP5 (>>) |
CFL1 → MAP2K2 (>>) |
CFL1 → MAPKAP1 (>>) |
CFL1 → MEF2D (>>) |
CFL1 → NUPR1 (>>) |
CFL1 → PKM2 (>>) |
CFL1 → PLD3 (>>) |
CFL1 → PPP1CA (>>) |
CFL1 → RAB5C (>>) |
CFL1 → RAC3 (>>) |
CFL1 → RARG (>>) |
CFL1 → RHOB (>>) |
CFL1 → RHOC (>>) |
CFL1 → RHOD (>>) |
CFL1 → RPL35 (>>) |
CFL1 → RPL36 (>>) |
CFL1 → RPS16 (>>) |
CFL1 → RRAS (>>) |
CFL1 → RXRB (>>) |
CFL1 → SH3GLB2 (>>) |
CFL1 → SHC1 (>>) |
CFL1 → SLC29A1 (>>) |
CFL1 → SLC45A3 (>>) |
CFL1 → STK16 (>>) |
CFL1 → SULT1A1 (>>) |
CFL1 → TAGLN2 (>>) |
CFL1 → TCEB1 (>>) |
CFL1 → TGFB1 (>>) |
CFL1 → TMEFF2 (>>) |
CFL1 → TPM4 (>>) |
CFL1 → TRIB1 (>>) |
CFL1 → TUBA1B (>>) |
CFL1 → TUBB2C (>>) |
CFL1 → VEGFB (>>) |
CFL1 → YWHAE (>>) |
CFL1 → ZFP36L1 (>>) |